title: Antiidiotype (Ab2) vaccine therapy for cutaneous T-cell lymphoma.
authors.affiliation: Markey Cancer Center, University of Kentucky, Lexington 40536.
authors.forename: M
authors.initials: M
authors.lastname: Chatterjee
authors.forename: E
authors.initials: E
authors.lastname: Mrozek
authors.forename: L
authors.initials: L
authors.lastname: Vaickus
authors.forename: A
authors.initials: A
authors.lastname: Oseroff
authors.forename: H
authors.initials: H
authors.lastname: Stoll
authors.forename: D
authors.initials: D
authors.lastname: Russell
authors.forename: H
authors.initials: H
authors.lastname: Kohler
authors.forename: K A
authors.initials: KA
authors.lastname: Foon
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D008213:Lymphocyte Activation; D016410:Lymphoma, T-Cell, Cutaneous / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal